News & Updates

ADHD medication use carries no excess risk of cardiovascular diseases
ADHD medication use carries no excess risk of cardiovascular diseases
02 Dec 2022

Users of attention-deficit/hyperactivity disorder (ADHD) medications across age groups do not appear to be at increased risk of cardiovascular diseases (CVDs), although a modest risk increase of cardiac arrest or tachyarrhythmias could not be ruled out, according to the results of a meta-analysis.

ADHD medication use carries no excess risk of cardiovascular diseases
02 Dec 2022
SG, HK docs delay prescribing clozapine for treatment-resistant schizophrenia
SG, HK docs delay prescribing clozapine for treatment-resistant schizophrenia
02 Dec 2022
ENT-01 relieves constipation in patients with Parkinson’s disease
ENT-01 relieves constipation in patients with Parkinson’s disease
02 Dec 2022
Maximum home BP predicts cardiovascular outcomes in T2D patients
Maximum home BP predicts cardiovascular outcomes in T2D patients
02 Dec 2022

In patients with type 2 diabetes (T2D), maximum home blood pressure (BP) may be used as a potential marker of subsequent cardiovascular events, suggests a retrospective cohort study.

Maximum home BP predicts cardiovascular outcomes in T2D patients
02 Dec 2022
IV iron cuts risk of HF rehospitalization, CV death in ambulatory HFrEF patients
IV iron cuts risk of HF rehospitalization, CV death in ambulatory HFrEF patients
02 Dec 2022
Esophagogastric junction biopsy may be forgone after endoscopic eradication of BE
Esophagogastric junction biopsy may be forgone after endoscopic eradication of BE
02 Dec 2022